Literature DB >> 18156498

Expansion of immunoglobulin autoreactive T-helper cells in multiple myeloma.

Masih Ostad1, Margareta Andersson, Astrid Gruber, Anne Sundblad.   

Abstract

Activation and expansion of T helper (Th) cells followed by regulation of activation are essential to the generation of immune responses while limiting concomitant autoreactivity. In order to characterize T cells reactive towards myeloma-derived monoclonal immunoglobulin (mIg), an autologous coculture assay for single-cell analysis of mIg-responding cells was developed. When cultured with dendritic cells loaded with mIg, CD4(+) Th cells from patients with progressing multiple myeloma (MM) showed a proliferative MHC class II-dependent response. CD8(+) T-cell reactivity and Th1 activation were consistently low or absent, and Th2 and regulatory cytokines were expressed. The presence of such non-Th1 CD4(+) T cells in peripheral blood was independent of treatment status, while the frequencies of responding cells varied between patients and reached the same order of magnitude as those measured for tetanus toxoid-specific Th memory cells. Furthermore, investigations of T-cell subpopulations indicated a possible regulatory role on the mIg responsiveness mediated by suppressive CD25(high)FOXP3(+)CD4(+) T cells. It is proposed from the present results that a predominant in vivo activation of non-Th1 mIg-reactive CD4(+) T cells constitute an Ig-dependent autoregulatory mechanism in human MM, with possible tumor growth supporting or permissive effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156498     DOI: 10.1182/blood-2006-11-056242

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.

Authors:  Myriam Foglietta; Barbara Castella; Sara Mariani; Marta Coscia; Laura Godio; Riccardo Ferracini; Marina Ruggeri; Vittorio Muccio; Paola Omedé; Antonio Palumbo; Mario Boccadoro; Massimo Massaia
Journal:  Haematologica       Date:  2014-06-27       Impact factor: 9.941

2.  Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy.

Authors:  Xia Zhao; Chun-Yan Ji; Guo-Qiang Liu; Dao-Xin Ma; Hui-Fang Ding; Min Xu; Jian Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.

Authors:  Fiona A Harding; Marcia M Stickler; Jennifer Razo; Robert B DuBridge
Journal:  MAbs       Date:  2010-05-01       Impact factor: 5.857

4.  Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice.

Authors:  D Wang; Y Fløisand; C V Myklebust; S Bürgler; A Parente-Ribes; P O Hofgaard; B Bogen; K Taskén; G E Tjønnfjord; F Schjesvold; J Dalgaard; A Tveita; L A Munthe
Journal:  Leukemia       Date:  2017-02-24       Impact factor: 11.528

5.  Enhancement of myeloma development mediated though myeloma cell-Th2 cell interactions after microbial antigen presentation by myeloma cells and DCs.

Authors:  F Tian; J Li; Y Li; S Luo
Journal:  Blood Cancer J       Date:  2012-06-15       Impact factor: 11.037

6.  Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.

Authors:  Arianna Calcinotto; Maurilio Ponzoni; Roberto Ria; Matteo Grioni; Elena Cattaneo; Isabella Villa; Maria Teresa Sabrina Bertilaccio; Marta Chesi; Alessandro Rubinacci; Giovanni Tonon; P Leif Bergsagel; Angelo Vacca; Matteo Bellone
Journal:  Oncoimmunology       Date:  2015-05-07       Impact factor: 8.110

Review 7.  How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

Authors:  Ole Audun Werner Haabeth; Anders Aune Tveita; Marte Fauskanger; Fredrik Schjesvold; Kristina Berg Lorvik; Peter O Hofgaard; Hilde Omholt; Ludvig A Munthe; Zlatko Dembic; Alexandre Corthay; Bjarne Bogen
Journal:  Front Immunol       Date:  2014-04-15       Impact factor: 7.561

8.  Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study.

Authors:  Ji-Nuo Wang; Xin-Xin Cao; Ai-Lin Zhao; Hao Cai; Xuan Wang; Jian Li
Journal:  Cancer Cell Int       Date:  2018-11-19       Impact factor: 5.722

9.  Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2-myeloma cell interaction.

Authors:  Faqing Tian; Bo Lu; Ziren Chen; Junru Liu; Delan Ji; Juheng Li; Meiqin Tang; Wei Zhu; Juan Li
Journal:  BMC Cancer       Date:  2019-12-23       Impact factor: 4.430

10.  Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report.

Authors:  Satoko Oka; Kazuo Ono; Masaharu Nohgawa
Journal:  J Med Case Rep       Date:  2018-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.